Approval · Notice of Compliance 6804 · 2005
ALLOPRIN: Notice of Compliance 6804
Issued May 18, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 6804
- Date
- May 18, 2005
- Company
- Valeant Canada LpLaval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Xanthine oxidase inhibitor
Products in this notice
Medicinal ingredients
- ALLOPURINOL 100 MG per TAB
- ALLOPURINOL 200 MG per TAB
- ALLOPURINOL 300 MG per TAB